The US government has signed another big coronavirus vaccine supply deal, snapping up 100 million doses of Moderna’s mRNA jab for a little over $1.5 billion –around $15 per dose or $30 per ...
Washington: The United States has made an agreement with the pharmaceutical company Moderna to deliver 100 million doses of their novel coronavirus vaccine once it becomes available, said ...
GSK reached a licensing agreement with mRNA-vaccine developer CureVac worth up to $1.8 billion to develop its vaccines for ...
CureVac's share price has plummeted over 90% in the past five years due to vaccine efficacy issues and legal disputes. Learn ...
(Reuters) -The U.S. government is nearing an agreement to fund a late-stage trial of Moderna's mRNA bird flu vaccine, the Financial Times reported on Thursday, as the outbreak spreads in dairy ...
Shares of Moderna (MRNA) are falling after the company said its newly approved RSV vaccine was only about 50% effective ...
Carisma Therapeutics (NASDAQ:CARM) climbed ~29% premarket Friday after the cell therapy developer said it would receive $2M ...